Nature Clinical Practice Endocrinology & Metabolism
Clinical Implications of a Molecular Genetic Classification of Monogenic Beta-cell Diabetes CME

Disclosures

Release Date: February 26, 2008; Valid for credit through February 26, 2009
Credits Available
Physicians - maximum of 1.0 AMA PRA Category 1 Credit(s)™ for physicians

Contents of This CME Activity
    To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

  1. Clinical Implications of a Molecular Genetic Classification of Monogenic Beta-cell Diabetes
    Rinki Murphy, MBChB
    Sian Ellard, PhD, MRCPath
    Andrew T. Hattersley, BMBCh, MA, DM, FRCP

Go to Test Questions

 
Legal Disclaimer
The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.
Copyright © 2008 Medscape.

 
Medscape
Learning Objectives

Upon completion of this activity, participants will be able to:

  1. List the 4 proposed clinical subtypes of monogenic diabetes
  2. Describe the clinical features of glucokinase hyperglycemia/diabetes
  3. Describe the criteria for testing to distinguish diabetes caused by hepatocyte nuclear factor-1alpha (HNF-1alpha) mutations from type 1 and 2 diabetes
  4. Describe the clinical features of permanent and transient neonatal diabetes
Authors and Disclosures

Rinki Murphy, MBChB
Disclosure: Rinki Murphy, MBChB, has disclosed no relevant financial relationships.


Sian Ellard, PhD, MRCPath
Disclosure: Sian Ellard, PhD, MRCPath, has disclosed no relevant financial relationships.


Andrew T. Hattersley, BMBCh, MA, DM, FRCP
Disclosure: Andrew T. Hattersley, BMBCh, MA, DM, FRCP, has disclosed no relevant financial relationships.


Désirée Lie, MD, MSEd
Disclosure: Désirée Lie, MD, MSEd, has disclosed no relevant financial relationships.
 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.